BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38175123)

  • 1. CTCF regulates hepatitis B virus cccDNA chromatin topology.
    Dobrica MO; Varghese CS; Harris JM; Ferguson J; Magri A; Arnold R; Várnai C; Parish JL; McKeating JA
    J Gen Virol; 2024 Jan; 105(1):. PubMed ID: 38175123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCCTC-binding factor CTCF represses hepatitis B virus enhancer I and regulates viral transcription.
    D'Arienzo V; Ferguson J; Giraud G; Chapus F; Harris JM; Wing PAC; Claydon A; Begum S; Zhuang X; Balfe P; Testoni B; McKeating JA; Parish JL
    Cell Microbiol; 2021 Feb; 23(2):e13274. PubMed ID: 33006186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
    Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
    J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.
    Rivière L; Gerossier L; Ducroux A; Dion S; Deng Q; Michel ML; Buendia MA; Hantz O; Neuveut C
    J Hepatol; 2015 Nov; 63(5):1093-102. PubMed ID: 26143443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status.
    Koumbi L; Pollicino T; Raimondo G; Stampoulis D; Khakoo S; Karayiannis P
    Virus Res; 2016 Jul; 220():150-60. PubMed ID: 27132039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
    Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
    J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIRA Supports Hepatitis B Virus Minichromosome Establishment and Transcriptional Activity in Infected Hepatocytes.
    Locatelli M; Quivy JP; Chapus F; Michelet M; Fresquet J; Maadadi S; Aberkane AN; Diederichs A; Lucifora J; Rivoire M; Almouzni G; Testoni B; Zoulim F
    Cell Mol Gastroenterol Hepatol; 2022; 14(3):527-551. PubMed ID: 35643233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chromatin insulator CTCF regulates HPV18 transcript splicing and differentiation-dependent late gene expression.
    Ferguson J; Campos-León K; Pentland I; Stockton JD; Günther T; Beggs AD; Grundhoff A; Roberts S; Noyvert B; Parish JL
    PLoS Pathog; 2021 Nov; 17(11):e1010032. PubMed ID: 34735550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.
    Tropberger P; Mercier A; Robinson M; Zhong W; Ganem DE; Holdorf M
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5715-24. PubMed ID: 26438841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System.
    Ding J; Yi Z; Zai W; Wu M; Chen B; Cai Q; Zhang X; Yuan Z
    mBio; 2023 Apr; 14(2):e0355022. PubMed ID: 36840581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
    Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA.
    Meier-Stephenson V; Badmalia MD; Mrozowich T; Lau KCK; Schultz SK; Gemmill DL; Osiowy C; van Marle G; Coffin CS; Patel TR
    J Biol Chem; 2021; 296():100589. PubMed ID: 33774051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
    Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
    Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
    Kim ES; Zhou J; Zhang H; Marchetti A; van de Klundert M; Cai D; Yu X; Mitra B; Liu Y; Wang M; Protzer U; Guo H
    PLoS Pathog; 2022 Jun; 18(6):e1010576. PubMed ID: 35679251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription.
    Yu X; Long Q; Shen S; Liu Z; Chandran J; Zhang J; Ding H; Zhang H; Cai D; Kim ES; Huang Y; Guo H
    Antiviral Res; 2023 Mar; 211():105552. PubMed ID: 36737008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.